Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-15-007835
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-09 16:37:47
Reporting Period:
2015-02-05
Filing Date:
2015-02-09
Accepted Time:
2015-02-09 16:37:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
890465 Nps Pharmaceuticals Inc NPSP Biological Products, (No Disgnostic Substances) (2836) 870439579
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1299691 J Joseph Rogus 550 Hills Drive
Bedminster NJ 07921
Svp, Gto & Supply Chain Mngmt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-05 16,875 $8.25 37,026 No 4 M Direct
Common Stock Acquisiton 2015-02-05 11,434 $8.23 48,460 No 4 M Direct
Common Stock Acquisiton 2015-02-05 4,313 $3.34 52,773 No 4 M Direct
Common Stock Disposition 2015-02-05 32,622 $45.90 20,151 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2015-02-05 16,875 $0.00 16,875 $8.25
Common Stock Employee Stock Options (right to buy) Disposition 2015-02-05 11,434 $0.00 11,434 $8.23
Common Stock Employee Stock Options (right to buy) Disposition 2015-02-05 4,313 $0.00 4,313 $3.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,813 2021-02-17 No 4 M Direct
14,702 2023-02-13 No 4 M Direct
69,738 2020-02-19 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.89 to $45.93, inclusive. The reporting person undertakes to provide to NPS Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
  2. On February 17, 2011, the reporting person received a grant of 45,000 stock options under the Issuer's 1998 Stock Option Plan. The options became exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
  3. On February 13, 2013, the reporting person received a grant of 26,136 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options became exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
  4. On February 19, 2010, the reporting person was granted options to purchase shares of common stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. As of the date of this filing, the performance criteria and the time-based criteria for 112,125 of these options has been satisfied. These options vested and became exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.